These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34241700)

  • 1. Symptom clusters and their influence on prognosis using EORTC QLQ-C15-PAL scores in terminally ill patients with cancer.
    Koyama N; Matsumura C; Tahara Y; Sako M; Kurosawa H; Nomura T; Eguchi Y; Ohba K; Yano Y
    Support Care Cancer; 2022 Jan; 30(1):135-143. PubMed ID: 34241700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Patient Self-Reported Quality of Life and Health Care Professional-Assessed Symptoms in Terminally ill Patients With Cancer.
    Matsumura C; Koyama N; Sako M; Kurosawa H; Nomura T; Eguchi Y; Ohba K; Yano Y
    Am J Hosp Palliat Care; 2021 Mar; 38(3):283-290. PubMed ID: 32705893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of EORTC QLQ-C15-PAL scores and inflammatory biomarkers in predicting survival in terminally ill patients with cancer.
    Koyama N; Matsumura C; Shitashimizu Y; Sako M; Kurosawa H; Nomura T; Eguchi Y; Ohba K; Yano Y
    BMC Cancer; 2021 Mar; 21(1):304. PubMed ID: 33757453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer.
    Lee YJ; Suh SY; Choi YS; Shim JY; Seo AR; Choi SE; Ahn HY; Yim E
    Support Care Cancer; 2014 Jul; 22(7):1941-8. PubMed ID: 24577883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Prediction of Patients Who Were Terminally Ill Using the EORTC QLQ-C15-PAL Scores and Laboratory Test Values.
    Matsumura C; Koyama N; Okuno K; Nakamura N; Sako M; Kurosawa H; Nomura T; Eguchi Y; Ohba K; Yano Y
    Palliat Med Rep; 2023; 4(1):202-207. PubMed ID: 37637762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life in a Hospice: A Validation of the Croatian Version of the EORTC QLQ-C15-PAL.
    Golčić M; Dobrila-Dintinjana R; Golčić G; Pavlović-Ružić I; Stevanović A; Gović-Golčić L
    Am J Hosp Palliat Care; 2018 Aug; 35(8):1085-1090. PubMed ID: 29466864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Mexican-Spanish version of the EORTC QLQ-C15-PAL questionnaire for the evaluation of health-related quality of life in patients on palliative care.
    Suárez-del-Real Y; Allende-Pérez S; Alférez-Mancera A; Rodríguez RB; Jiménez-Toxtle S; Mohar A; Oñate-Ocaña LF
    Psychooncology; 2011 Aug; 20(8):889-96. PubMed ID: 20662106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy.
    Caissie A; Culleton S; Nguyen J; Zhang L; Zeng L; Holden L; Dennis K; Chan E; Jon F; Tsao M; Danjoux C; Sahgal A; Barnes E; Koo K; Chow E
    Support Care Cancer; 2012 Apr; 20(4):841-8. PubMed ID: 21538099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-cultural verification of the EORTC QLQ-C15-PAL questionnaire in mainland China.
    Zhang L; Wang N; Zhang J; Liu J; Luo Z; Sun W; Woo SM; Chen C; Zhang K; Miller AR; Guo H; Zhang X; Wang C
    Palliat Med; 2016 Apr; 30(4):401-8. PubMed ID: 26121985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Content validation of the EORTC QLQ-C15-PAL with advanced cancer patients and health care professionals from palliative care services in Chile.
    Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
    BMC Palliat Care; 2020 Jun; 19(1):81. PubMed ID: 32517678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors of overall well-being using the EORTC QLQ-C15-PAL extracted from the EORTC QLQ-C30.
    Lam K; Zeng L; Zhang L; Tseng LM; Hou MF; Fairchild A; Vassiliou V; Jesus-Garcia R; Alm El-Din MA; Kumar A; Forges F; Chie WC; Sahgal A; Poon M; Chow E
    J Palliat Med; 2013 Apr; 16(4):402-8. PubMed ID: 23458649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability and validity of the Turkish version of the EORTC QLQ-C15-PAL for patients with advanced cancer.
    Ozcelik H; Guzel Y; Sonmez E; Aksoy F; Uslu R
    Palliat Support Care; 2016 Dec; 14(6):628-634. PubMed ID: 27068607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verification of the psychometric properties of the Japanese version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 palliative (EORTCQLQ-C15-PAL).
    Miyazaki K; Suzukamo Y; Shimozuma K; Nakayama T
    Qual Life Res; 2012 Mar; 21(2):335-40. PubMed ID: 21643874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Which symptoms and problems do advanced cancer patients admitted to specialized palliative care report in addition to those included in the EORTC QLQ-C15-PAL? A register-based national study.
    Rojas-Concha L; Hansen MB; Petersen MA; Groenvold M
    Support Care Cancer; 2020 Apr; 28(4):1725-1735. PubMed ID: 31297593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quality of life of Brazilian patients in palliative care: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 PAL (EORTC QLQ-C15-PAL).
    Nunes NA
    Support Care Cancer; 2014 Jun; 22(6):1595-600. PubMed ID: 24463615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal important differences in the EORTC QLQ-C15-PAL to determine meaningful change in palliative advanced cancer patients.
    Bedard G; Zeng L; Zhang L; Lauzon N; Holden L; Tsao M; Danjoux C; Barnes E; Sahgal A; Poon M; Hicks K; Chow E
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e38-46. PubMed ID: 23551493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).
    King MT; Agar M; Currow DC; Hardy J; Fazekas B; McCaffrey N
    Support Care Cancer; 2020 Jan; 28(1):141-153. PubMed ID: 30993452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the Thresholds for Clinical Importance of the EORTC QLQ-C15-PAL in Patients Receiving Palliative Treatment.
    Pilz MJ; Aaronson NK; Arraras JI; Caocci G; Efficace F; Groenvold M; Holzner B; van Leeuwen M; Loth FLC; Petersen MA; Ramage J; Tomaszewski KA; Young T; Giesinger JM
    J Palliat Med; 2021 Mar; 24(3):397-404. PubMed ID: 32835601
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive factors for overall quality of life in patients with advanced cancer.
    Cramarossa G; Chow E; Zhang L; Bedard G; Zeng L; Sahgal A; Vassiliou V; Satoh T; Foro P; Ma BB; Chie WC; Chen E; Lam H; Bottomley A
    Support Care Cancer; 2013 Jun; 21(6):1709-16. PubMed ID: 23338229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.